Performance-enhancing
drugs
IOC (International Olympic Committee) Restrictions:
I. Prohibited Classes of Substances:
1. stimulants - caffieine, aphetamines (>12 microgram/ml
for caffeine);
-
increase competitiveness
-
increased BP and body temp.
2. narcotics
-
reduce pain especially with injury
-
cocaine abuse
3. anabolic agents*
4. diuretics*
5. peptide and glycoprotein hormones and analogs*
II. Prohibited Methods
1. Blood doping*
2. pharmacological, chemical, and physical manipulation
of samples
III.Classes of Drugs Subject to Restriction
alcohol
marijuana
local anesthetics
corticosteroids
beta-blockers*
Anabolic Androgenic Steroids
(such as testosterone)
-
over 100 different steroids exist; oral or injection
-
"stacking" and "cycling" are common practices
Mechanism of Action:
-
Anabolic steroids bind to androgen receptors on cells, stimulating increased
protein synthesis.
Performance-enhancing effects:
-
increased strength
-
increased muscle mass
-
ability to endure intensified training regimens (mood and aggression, recovery)
Sports of Use:
-
weight-lifting
-
track and field
-
swimming
Adverse Outcomes:
-
cardiovascular disease
-
liver dysfunction
-
increased aggression
-
damage to muscles and tendons
-
hypogonadism (infertility)-
-
shrunken testes in men (reversed by use of pituitary hormone)
Additional outcomes in women:
-
atrophy of breasts and uterus
-
male pattern baldness
-
menstrual abnormalities
-
teratogenicity
-
Hirsutism - the presence of excess hair growth in women
-
acne
-
deepening of voice
-
clitoral hypertrophy
Testing Issues:
-
training aids vs. competition aids; athletes may stop weeks before an event
to allow "clearance time"
-
"masking", i.e. use of diuretics to increase dilution; spiking with epitestosterone
-
Urine Testing: testosterone/epitestosterone ratio (>6:1)
rhEPO - recombinant
human Erythropoietin
Mechanism of Action:
-
hormone that stimulates the production of red blood cells (erythropoiesis)
Performance-enhancing effects:
-
increases production of red blood cells
-
increases delivery of oxygen to tissues
-
improves endurance
-
10-15% improvements in performance
Sports of Use:
-
cycling (drug of the 1998 Tour de France scandal)
-
tennis
-
running
-
cross country skiing
Adverse Health Outcomes:
-
increases blood viscosity (thickness)
-
replicates the disease "polycythaemia", which makes blood viscous
-
leads to clogging of arteries, stroke, heart attack
-
**exacerbated by dehydrating effects of endurance sports (concomitant
decrease in blood volume)
Suspected Incidence:
-
"Rampant"
-
In a study of 102 frozen urine samples from the 1998 Tour de France, 28
samples had elevated EPO levels; researchers analyzed the 14 samples with
highest concentrations: all 14 had confirmed recombinant EPO (Nature June
8, 2000)
Differing Effects of Gender:
? unknown
Testing:
-
recent introduction of blood test for EPO, in time for the Sydney Olympics
-
urine test differentiates between exogenous and endogenous EPO through
immunoblotting assay
Beta Blockers (restricted
substance)
Performance-enhancing effects:
calms nerves and steadies hands
Sports of Use:
Also Banned in:
-
luge
-
ski-jumping
-
diving
-
synchronized swimming
-
modern pentathalon
Adverse Health Outcomes:
-
bradycardia (slow heart beat, as seen in AN)
-
may constrict blood vessels
Incidence:
-
unknown, but available OTC
Diuretics
Sports of Use:
-
weight-lifting
-
wrestling
-
judo
Action:
-
reduces weight, through water loss
-
increases urine volume
-
masks drugs in urine
Dangers:
-
severe dehydration
-
heart damage
-
kidney failure
-
cases of pulmonary embolism reported in wrestlers
Testing:
Blood-Doping
-
Reinject your own blood (previously frozen) to increase red blood
cells.
Sports:
Mechanism of Action:
-
increases packed-cell volume
Adverse Outcomes:
-
associated with unexplained death in some endurance athletes
-
increased blood viscosity (similar to EPO)
-
increased blood volume
-
logistically complicated; opportunities for infection and contamination
Testing:
-
difficult to detect
-
can test packed-cell volume
Human growth hormone
(hGH), Insulin-Like Growth Factor-1 , human chorionic gonadotropin, insulin
Mechanism of Action/Performance-enhancing effects
-
peptide hormones that build muscle size and strength (anabolism)
-
reduce bodyfat (lipolysis)
-
increase bone mass
-
increase red-blood cell mass and cardiac function
-
effect carbohydrate metabolism
Gender differences:
-
hCG increases production of natural sex hormones (i.e. testosterone in
males)
-
hCG is not banned in women
Adverse Outcomes:
-
hGH associated with a fatal neurological disorder
-
hGH causes acromegaly (overgrowth of feet, hands, face)
-
IGF-1 may cause heart enlargement
-
cardiomyopathy
-
hypertension
-
myopathy
-
malignancy
-
peripheral neuropathy
-
glucose intolerance
-
hypoglycemia and coma (insulin)
Testing:
-
no routine tests available for IGF-1 or hGH,
-
screening and mass spectrometry tests are available for human chorionic
gonadotropin